Q1 FY2027 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Astellas Pharma(ALPMY) the Revenue is 3.958 B (+13.27%), Beat estimate;the EBIT is 1.139 B (+74.26%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
3.96B13.27%
3.47B0.75%
+0.49B14.02%
EBITExceed expectations
1.14B74.26%
0.83B27.58%
+0.31B46.68%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf